Sensitization against medical hyaluronidase in patients with confirmed hypersensitivity against hymenoptera species and its clinical implications.

IF 11 1区 医学 Q1 DERMATOLOGY
Mattis Bertlich, Daniela Hartmann, Saskia Freytag, Lars E French, Eva Oppel
{"title":"Sensitization against medical hyaluronidase in patients with confirmed hypersensitivity against hymenoptera species and its clinical implications.","authors":"Mattis Bertlich, Daniela Hartmann, Saskia Freytag, Lars E French, Eva Oppel","doi":"10.1093/bjd/ljae290","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hyaluronidase is an ubiquitous enzyme, present, among others, in hymenoptera venom and in medical formulations. The latter include use as an emergency treatment or to correct undesired outcomes of medical and aesthetic procedures using hyaluronic acid fillers.</p><p><strong>Objectives: </strong>By performing detailed allergy work-ups including skin-prick tests (SPTs) we investigated whether patients with a history of allergic reaction to hymenoptera venom are also sensitized to medical grade hyaluronidase.</p><p><strong>Methods: </strong>Ninety patients with a history of type-1 reaction to hymenoptera venom with and without a history of previous specific venom immunotherapy were included in the study. All underwent SPTs for medical hyaluronidase. All patients also underwent serological analysis for Api m2, the only commercially available IgE test for a hymenoptera hyaluronidase.</p><p><strong>Results: </strong>Of the 90 patients with previous type-1 reactions to hymenoptera venom hyaluronidase included in the study, 60 had undergone previous venom immunotherapy; 30 did not. The majority (73 of 90) were allergic to wasps, followed by honeybees (14 of 90) and three were allergic to both. Neither patients having undergone previous immunotherapy nor those allergic to bees showed positive SPTs to medical hyaluronidase. Of those with a wasp allergy and naïve to immunotherapy, over 20% (5 of 23) showed positive SPTs to medical hyaluronidase. Healthy controls (0 of 30) without previous allergic reactions to hymenoptera did not show positive SPTs to medical hyaluronidase.</p><p><strong>Conclusions: </strong>Sensitization to hyaluronidase is most common in wasp-allergic patients who have not had previous specific immunotherapy. As allergic reactions to medical hyaluronidase are reported to be scarce, this group is probably at the highest risk to develop anaphylaxis to medical hyaluronidase. While all patients with untreated anaphylaxis to hymenoptera venom should consult an allergy specialist, it is particularly important that those with untreated wasp allergies seek specialist advice before treatment with medical hyaluronidase is initiated.</p>","PeriodicalId":9238,"journal":{"name":"British Journal of Dermatology","volume":" ","pages":"1000-1007"},"PeriodicalIF":11.0000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Dermatology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1093/bjd/ljae290","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hyaluronidase is an ubiquitous enzyme, present, among others, in hymenoptera venom and in medical formulations. The latter include use as an emergency treatment or to correct undesired outcomes of medical and aesthetic procedures using hyaluronic acid fillers.

Objectives: By performing detailed allergy work-ups including skin-prick tests (SPTs) we investigated whether patients with a history of allergic reaction to hymenoptera venom are also sensitized to medical grade hyaluronidase.

Methods: Ninety patients with a history of type-1 reaction to hymenoptera venom with and without a history of previous specific venom immunotherapy were included in the study. All underwent SPTs for medical hyaluronidase. All patients also underwent serological analysis for Api m2, the only commercially available IgE test for a hymenoptera hyaluronidase.

Results: Of the 90 patients with previous type-1 reactions to hymenoptera venom hyaluronidase included in the study, 60 had undergone previous venom immunotherapy; 30 did not. The majority (73 of 90) were allergic to wasps, followed by honeybees (14 of 90) and three were allergic to both. Neither patients having undergone previous immunotherapy nor those allergic to bees showed positive SPTs to medical hyaluronidase. Of those with a wasp allergy and naïve to immunotherapy, over 20% (5 of 23) showed positive SPTs to medical hyaluronidase. Healthy controls (0 of 30) without previous allergic reactions to hymenoptera did not show positive SPTs to medical hyaluronidase.

Conclusions: Sensitization to hyaluronidase is most common in wasp-allergic patients who have not had previous specific immunotherapy. As allergic reactions to medical hyaluronidase are reported to be scarce, this group is probably at the highest risk to develop anaphylaxis to medical hyaluronidase. While all patients with untreated anaphylaxis to hymenoptera venom should consult an allergy specialist, it is particularly important that those with untreated wasp allergies seek specialist advice before treatment with medical hyaluronidase is initiated.

已确认对膜翅目物种过敏的患者对医用透明质酸酶的过敏反应及其临床意义。
背景:透明质酸酶是一种无处不在的酶,主要存在于膜翅目昆虫的毒液和医疗制剂中。后者包括用作紧急治疗或使用透明质酸填充剂纠正医疗和美容手术的不良后果。通过详细的过敏检查(包括点刺试验),我们在此调查了对珙桐毒液有过敏史的患者是否也会对医用透明质酸酶过敏:本研究共纳入了 90 名对膜翅目昆虫毒液有 1 型反应史的患者,这些患者既往接受过特异性毒液免疫疗法,也未接受过此类疗法。所有患者都接受了医用透明质酸酶皮肤点刺试验。所有患者还进行了 Api m2 血清学分析,这是目前市场上唯一一种姬蜂透明质酸酶 IgE 检测方法:结果:90 名曾对膜翅目昆虫毒液透明质酸酶有 1 型反应的患者中,60 人曾接受过毒液免疫疗法,30 人没有。大多数患者(73/90)对黄蜂过敏,其次是蜜蜂(14/90),3 人对两者都过敏。既往接受过免疫疗法的患者和对蜜蜂过敏的患者对医用透明质酸酶的皮肤点刺试验均未呈阳性反应。在对黄蜂过敏且未接受免疫疗法的患者中,超过 20% 的患者(5/23)对医用透明质酸酶的皮肤点刺试验呈阳性反应。健康对照组(0/30)既往未对膜翅目昆虫有过过敏反应,对医用透明质酸酶的皮肤点刺试验也未呈阳性反应:结论:对透明质酸酶过敏最常见于既往未接受过特异性免疫治疗的黄蜂过敏症患者。据报道,对医用透明质酸酶过敏的人很少,因此这部分人可能是对医用透明质酸酶过敏风险最高的人群。所有对嗜膜翅目昆虫毒液过敏但未经治疗的患者都应咨询过敏专科医生,尤其是那些对黄蜂过敏但未经治疗的患者,在开始使用医用透明质酸酶治疗前应征求专科医生的意见。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
British Journal of Dermatology
British Journal of Dermatology 医学-皮肤病学
CiteScore
16.30
自引率
3.90%
发文量
1062
审稿时长
2-4 weeks
期刊介绍: The British Journal of Dermatology (BJD) is committed to publishing the highest quality dermatological research. Through its publications, the journal seeks to advance the understanding, management, and treatment of skin diseases, ultimately aiming to improve patient outcomes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信